DAPAGLIFLOZIN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70377-024 -
Package NDC
70377-024-11 -
Package NDC
70377-024-12 -
Application number
ANDA211470 -
SPL ID
f23d20a0-8e57-6f45-e23b-0fffcb2f8652 -
SPL set ID
828f1004-3647-9a13-8008-c4b3759ecfd0 -
UNII
U289305BKG -
RxCUI
1488569 -
RxCUI
1488574
What the source publishes
- Labeler
- Biocon Pharma Inc.
- Active ingredients
- DAPAGLIFLOZIN
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "DAPAGLIFLOZIN",
"splId": "f23d20a0-8e57-6f45-e23b-0fffcb2f8652",
"labels": [
{
"setId": "828f1004-3647-9a13-8008-c4b3759ecfd0",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=828f1004-3647-9a13-8008-c4b3759ecfd0",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=828f1004-3647-9a13-8008-c4b3759ecfd0"
}
],
"routes": [
"ORAL"
],
"labeler": "Biocon Pharma Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-024-11)",
"package_ndc": "70377-024-11",
"identifierStatus": "well-formed",
"marketing_start_date": "20260501"
},
{
"sample": false,
"description": "1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70377-024-12)",
"package_ndc": "70377-024-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20260501"
}
],
"productId": "70377-024_f23d20a0-8e57-6f45-e23b-0fffcb2f8652",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "70377-024",
"deaSchedule": null,
"genericName": "DAPAGLIFLOZIN",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA211470",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260501",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0370377024115",
"0370377023118"
],
"unii": [
"U289305BKG"
],
"rxcui": [
"1488569",
"1488574"
],
"spl_set_id": [
"828f1004-3647-9a13-8008-c4b3759ecfd0"
],
"manufacturer_name": [
"Biocon Pharma Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70377-024_f23d20a0-8e57-6f45-e23b-0fffcb2f8652"